2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F24%3A10001313" target="_blank" >RIV/00064190:_____/24:10001313 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.1016/j.ejim.2024.05.033" target="_blank" >https://doi.org/10.1016/j.ejim.2024.05.033</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ejim.2024.05.033" target="_blank" >10.1016/j.ejim.2024.05.033</a>

Jazyk výsledku

angličtina

Název v původním jazyce

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

Popis výsledku v původním jazyce

The European Society of Hypertension (ESH) reported in 2023 its current Guidelines for the management of arterial hypertension [1]. Following their aim to summarize the best available evidence for all aspects of hypertension management, the Task Force of the 2023 Guidelines generated a comprehensive document covering almost 200 pages including 1736 references [1]. This document thus provides a valuable and comprehensive source of information for hypertension management. However, due to the length of the text and its complexity, not only primary care providers (e.g. family physicians, general physicians/internists), who represent the group of physicians that manages the vast majority of patients, but also specialists may find it challenging to navigate through the extensive guidelines with its numerous recommendations. Therefore, the ESH decided to provide with its 2024 Clinical Practice Guidelines a novel concise format that supports the dissemination of the most important information of the Guidelines for the management of the general hypertensive population and its implementation into clinical practice. To this end, the ESH developed a MASTERplan for the management of hypertension (Fig. 1). For aspects that are (intentionally) not covered in this document and for the supporting literature readers are referred to the full text of the 2023 ESH Guidelines.

Název v anglickém jazyce

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

Popis výsledku anglicky

The European Society of Hypertension (ESH) reported in 2023 its current Guidelines for the management of arterial hypertension [1]. Following their aim to summarize the best available evidence for all aspects of hypertension management, the Task Force of the 2023 Guidelines generated a comprehensive document covering almost 200 pages including 1736 references [1]. This document thus provides a valuable and comprehensive source of information for hypertension management. However, due to the length of the text and its complexity, not only primary care providers (e.g. family physicians, general physicians/internists), who represent the group of physicians that manages the vast majority of patients, but also specialists may find it challenging to navigate through the extensive guidelines with its numerous recommendations. Therefore, the ESH decided to provide with its 2024 Clinical Practice Guidelines a novel concise format that supports the dissemination of the most important information of the Guidelines for the management of the general hypertensive population and its implementation into clinical practice. To this end, the ESH developed a MASTERplan for the management of hypertension (Fig. 1). For aspects that are (intentionally) not covered in this document and for the supporting literature readers are referred to the full text of the 2023 ESH Guidelines.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů